@article{ref1,
title="Impulsivity and stillness: NADA, pharmaceuticals, and psychotherapy in substance use and other DSM 5 disorders",
journal="Behavioral sciences (Basel, Switzerland)",
year="2015",
author="Carter, Kenneth and Olshan-Perlmutter, Michelle",
volume="5",
number="4",
pages="537-546",
abstract="Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity.  The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by patients, providers, and programs utilizing NADA is the sense of stillness, centering, and well-being. The induction of this attitude is seen as contributing to improved clinical outcomes including engagement and retention.  The attitude of stillness is also suggestive of a pathway to mitigating impulsivity. Impulsivity is associated with substance use disorders and other DSM 5 diagnoses.  Impulsivity has characteristics that are manifested clinically in behaviors such as disinhibition, poor self-control, lack of deliberation, thrill seeking, risk-taking. NADA holds promise as a useful treatment adjunct in the comprehensive management of disorders for which impulsivity is a prominent component.<p /> <p>Language: en</p>",
language="en",
issn="2076-328X",
doi="10.3390/bs5040537",
url="http://dx.doi.org/10.3390/bs5040537"
}